This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEJ9G0O2_L.jpg
Thermo Fisher said it would pay the Sweden-based provider of protein analysis products $26.00 per common share in cash.
The deal, expected to be completed by mid-2024, represents a premium of about 74% to Olink’s closing price on Monday.
